INTREPID POTASH INC (IPI)       60.91  -3.7 (-5.73%)

60.91  -3.7 (-5.73%)

US46121Y2019 - Common Stock


Fundamental Rating

Taking everything into account, IPI scores 7 out of 10 in our fundamental rating. IPI was compared to 122 industry peers in the Chemicals industry. IPI scores excellent points on both the profitability and health parts. This is a solid base for a good stock. A decent growth rate in combination with a cheap valuation! Better keep an eye on IPI. This makes IPI very considerable for value investing!.




Profitability

Profitability Rating


IPI has a Return On Assets of 35.03%. This is amongst the best returns in the industry. The industry average is 4.51%. IPI outperforms 100% of its industry peers.
IPI's Return On Equity of 40.22% is amongst the best returns of the industry. IPI outperforms 84% of its industry peers. The industry average return on equity is 15.65%.

IPI has a Profit Margin of 91.93%. This is amongst the best returns in the industry. The industry average is 7.03%. IPI outperforms 100% of its industry peers.
IPI has a good Piotroski-F score of 7.00. This indicates a good health and good profitability for IPI.
VS Industry

ROA (35.03%) VS Industry: 100% outperformed.

-270.89
35.03

ROE (40.22%) VS Industry: 84% outperformed.

0.17
216.50

Profit Margin (91.93%) VS Industry: 100% outperformed.

-88,245.93
91.93

Valuation

Valuation Rating


The Forward Price/Earnings Ratio of 11.73 indicates a rather cheap valuation of IPI.
IPI's low PEG Ratio, which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
Compared to an average industry price book ratio of 2.38, IPI is valued rather cheaply. On top of this, IPI is cheaper than 82% of the companies listed in the same industry.
When comparing the Enterprise Value to EBITDA ratio of IPI to the average industry ratio of 9.74, IPI is valued rather cheaply.

With a Price/Earnings Ratio of 15.08, IPI is valued correctly.
IPI's Price/Earning Ratio is in line with the industry average which is at 14.35.
With a price book ratio of 1.20, IPI is valued correctly.
VS Industry

Price/Earnings (15.08) VS Industry: 46% outperformed.

247.50
2.30

Price/Book (1.2) VS Industry: 82% outperformed.

32.68
0.01

Enterprise Value/ EBITDA (7.5) VS Industry: 66% outperformed.

116.83
0.71

Growth

Growth Rating


IPI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 399.26%, which is quite impressive.
The Earnings Per Share has been growing by 28.28% on average over the past 5 years. This is a very strong growth
The Revenue has grown by 48.30% in the past year. This is a very strong growth!
Based on estimates for the next 5 years, IPI will show a decrease in Earnings Per Share. The EPS will decrease by -5.74% on average per year.

The Revenue has been growing slightly by 4.97% on average over the past 5 years.
IPI is expected to show a decrease in Revenue. In the coming 5 years, the Revenue will decrease by -5.07% yearly.
The EPS growth is decreasing: in the next 5 years the growth will be less than in the last years.
The Revenue growth is decreasing: in the next 5 years the growth will be less than in the last years.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPSN/A 28.28% 399.26% 394.19% 65.3% 24.15% -5.74%
Revenue4.97% 9.08% 48.3% 42.65% 6.12% 1.65% -5.07%

Health

Health Rating


IPI has a Current Ratio of 2.75. This indicates that IPI is financially healthy and has no problem in meeting its short term obligations.
IPI is better placed than average in its industry to meet its short term obligations. Its Current Ratio is much better than the industry average of 1.99.
IPI is better placed than average in its industry to meet its short term obligations. Its Current Ratio is much better than the industry average of 1.30.
The Debt to Equity ratio for IPI is way better than the industry averages. IPI has a better rating than 90% of its industry peers.

An Altman-Z score of 5.81 indicates that IPI is not in any danger for bankruptcy at the moment.
IPI has one of the better Altman-Z scores in its industry. It is much better than the industry average of 2.93. IPI has a better score than 86% of its industry peers.
IPI has a good Piotroski-F score of 7.00. This indicates a good health and good profitability for IPI.
IPI has a Quick Ratio of 1.65. This is a normal value and indicates that IPI is financially healthy and should not expect problems in meeting its short term obligations.
VS Industry

Debt/Equity (0) VS Industry: 90% outperformed.

8.24
-4.23

Quick Ratio (1.65) VS Industry: 61% outperformed.

0.00
61.90

Current Ratio (2.75) VS Industry: 69% outperformed.

0.00
61.90

Altman-Z (5.81) VS Industry: 86% outperformed.

-295.60
204.94

Dividend

Dividend Rating


No dividends for IPI!.

IPI Daily chart

INTREPID POTASH INC60.91

NYSE:IPI (5/27/2022, 10:32:58 AM)-3.7 (-5.73%)

Chartmill FA Rating
GICS Sector Materials
GICS IndustryGroup Materials
GICS Industry Chemicals
Earnings (Last) 05-02 2022-05-02/amc Earnings (Next) 08-01 2022-08-01
Ins Owners 14.55% Inst Owners 52.86%
Market Cap 829.52M Analysts 44
Valuation
PE 15.08 Fwd PE 11.73
PEG (NY) 0.04 PEG (5Y) N/A
P/S 2.74 P/B 1.2
EV/EBITDA 7.5
Profitability
ROA 35.03% ROE 40.22%
PM 91.93 Asset Turnover 0.38
Growth
EPS 1Y 399.26% EPS 3Y 28.28%
EPS 5Y N/A EPS growth Q2Q 1188.89%
EPS Next Y 394.19% EPS Next 2Y 65.3%
EPS Next 3Y 24.15% EPS Next 5Y -5.74%
Revenue growth 1Y 48.3% Revenue growth 3Y 9.08%
Revenue growth 5Y 4.97% Revenue growth Q2Q 46.01%
Revenue Next Year 42.65% Revenue Next 2Y 6.12%
Revenue Next 3Y 1.65% Revenue Next 5Y -5.07%
Health
Current Ratio 2.75 Quick Ratio 1.65
Altman-Z 5.81 F-Score 7
Debt/Equity N/A
Dividend
Dividend Yield N/A Dividend Growth N/A
DP 0% Ex-Date N/A

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA